Posted On: 01/19/2016 9:17:04 AM
Post# of 72444
Absolutely. Physicians and researchers will take note. Phase I is for safety and any decent hint at efficacy CANNOT be ignored. Add to that that we safely cracked the P-53 conundrum and it makes for tantalizing headlines that investors cannot ignore.
Lastly, these patients deserve a cure.
Lastly, these patients deserve a cure.
(0)
(0)
***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.
Scroll down for more posts ▼
